XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Estimated Fair Value of Stock Options The fair value of each stock option granted in 2022, 2021 and 2020, was estimated on the date of grant using the following weighted-average assumptions.

 

 

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Dividend yield

 

 

3.0

%

 

 

3.6

%

 

 

4.0

%

Volatility

 

 

27.9

%

 

 

29.6

%

 

 

27.1

%

Risk-free interest rate

 

 

1.2

%

 

 

0.4

%

 

 

0.4

%

Expected life

 

10.0 years

 

 

5.5 years

 

 

5.3 years

 

Weighted average grant date fair value

 

$

8.60

 

 

$

3.45

 

 

$

2.56

 

 

Option Activity under Company's Stock Option Plans

The following table presents option activity under the Company’s stock option plans as of and for the year ended December 31, 2022.

 

 

 

Number of
Stock Options
Outstanding

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Term

 

 

Aggregate
Intrinsic Value

 

 

 

(In thousands)

 

 

 

 

 

(In years)

 

 

(In thousands)

 

Outstanding at January 1, 2022

 

 

414

 

 

$

17.98

 

 

 

 

 

 

 

Granted

 

 

66

 

 

 

22.47

 

 

 

 

 

 

 

Exercised

 

 

(116

)

 

 

16.61

 

 

 

 

 

 

 

Forfeited or expired

 

 

(46

)

 

 

19.11

 

 

 

 

 

 

 

Outstanding at December 31, 2022

 

 

318

 

 

$

19.25

 

 

 

6.78

 

 

$

2,067

 

Vested or expected to vest at December 31, 2022

 

 

318

 

 

$

19.25

 

 

 

6.78

 

 

$

2,067

 

Exercisable at December 31, 2022

 

 

152

 

 

$

18.24

 

 

 

5.37

 

 

$

1,147

 

Summary of Status of Company's Non-Vested Restricted Shares

The table below summarizes activity related to the Company’s non-vested RSAs and PRSUs for the year ended December 31, 2022.

 

 

 

Shares

 

 

Weighted
Average Fair
        Value

 

 

 

(In thousands)

 

 

 

 

Nonvested at January 1, 2022

 

 

663

 

 

$

19.83

 

Granted

 

 

675

 

 

 

22.82

 

Vested

 

 

(198

)

 

 

20.59

 

Forfeited

 

 

(71

)

 

 

22.22

 

Nonvested at December 31, 2022

 

 

1,069

 

(1)

$

21.37

 

 

(1) Includes 172,313 PRSUs. There are no restricted stock units outstanding.